Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

Also called NCT01341717

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 440 participants (enrolled count) (from the registry)
Sponsor
Jothydev's Diabetes and Research Centre (from the registry)
Registry
  • NCT NCT01341717
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01341717. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Glimepiride
Intervention (Drug)
Metformin
Intervention (Drug)
Insulin
Lead sponsor
Jothydev's Diabetes and Research Centre (class: other)

Record details

Record id
cardio:ct-nct01341717
Content hash
5a0ef8977f52e19947c5617d275603c9b886718780e00125810e3a5c1c79fd1f